MARTEK BIOSCIENCES CORP
S-8, EX-23.01, 2000-12-20
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MARTEK BIOSCIENCES CORP, S-8, EX-10.01, 2000-12-20
Next: FRANKLIN STRATEGIC MORTGAGE PORTFOLIO, 24F-2NT, 2000-12-20



<PAGE>   1




                                                                   EXHIBIT 23.01

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 333-_____), pertaining to the Martek Biosciences Corporation 1997 Stock
Option Plan, as amended of Martek Biosciences Corporation, of our report dated
December 14, 1999, with respect to the financial statements of Martek
Biosciences Corporation included in its Annual Report (Form 10-K) for the year
ended October 31, 1999, filed with the Securities and Exchange Commission.




                                                           /s/ Ernst & Young LLP

McLean, Virginia
December 19, 2000










© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission